1] Institute for Nutrisciences and Health, National Research Council Canada, Charlottetown, Prince Edward Island, Canada [2] Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada.
Nutr Diabetes. 2012 Jan 16;2(1):e26. doi: 10.1038/nutd.2011.21.
The overwhelming increase in the prevalence of overweight and obesity in recent years represents one of the greatest threats to the health of the developed world. Among current treatments, however, gastrointestinal (GI) surgery remains the only approach capable of achieving significant weight loss results with long-term sustainability. As the obesity prevalence approaches epidemic proportions, the necessity to unravel the mechanisms regulating appetite control has garnered significant attention. It is well known that physical activity and food intake regulation are the two most important factors involved in body weight control. To regulate food intake, the brain must alter appetite. With this realization has come increased efforts to understand the intricate interplay between gut hormones and the central nervous system, and the role of these peptides in food intake regulation through appetite modulation. This review discusses the central mechanisms involved in body weight regulation and explores a suite of well characterized and intensely investigated anorexigenic and orexigenic gut hormones. Their appetite-regulating capabilities, post-GI surgery physiology and emerging potential as anti-obesity therapeutics are then reviewed.
近年来,超重和肥胖的患病率呈压倒性增长,这是对发达国家健康的最大威胁之一。然而,在目前的治疗方法中,胃肠道(GI)手术仍然是唯一能够实现显著长期可持续减重效果的方法。随着肥胖患病率接近流行程度,阐明调节食欲控制的机制已引起广泛关注。众所周知,身体活动和食物摄入调节是控制体重的两个最重要的因素。为了调节食物摄入,大脑必须改变食欲。随着这一认识的提高,人们越来越努力地理解肠道激素与中枢神经系统之间的复杂相互作用,以及这些肽类通过食欲调节在食物摄入调节中的作用。本综述讨论了参与体重调节的中枢机制,并探讨了一系列特征明确且受到深入研究的食欲抑制剂和食欲激素。然后,回顾了它们的食欲调节能力、GI 手术后的生理学以及作为抗肥胖治疗药物的新兴潜力。